NASDAQ:FOLD
$12.17
(
6.85%
)
Friday, 2nd Jun 2023
Amicus Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $10.55 | $12.49 | Friday, 2nd Jun 2023 FOLD stock ended at $12.17. This is 6.85% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 6.97% from a day low at $11.40 to a day high of $12.20. |
| 90 days | $10.55 | $12.60 | |
| 52 weeks | $7.73 | $13.84 |
Historical Amicus Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $11.48 | $12.20 | $11.40 | $12.17 | 2 366 665 |
| 2023-06-01 | $11.28 | $11.54 | $11.06 | $11.39 | 1 173 815 |
| 2023-05-31 | $11.22 | $11.49 | $11.19 | $11.26 | 1 429 616 |
| 2023-05-30 | $11.08 | $11.30 | $10.93 | $11.19 | 1 216 769 |
| 2023-05-26 | $11.11 | $11.24 | $10.99 | $11.11 | 1 325 549 |
| 2023-05-25 | $11.68 | $11.68 | $11.09 | $11.14 | 1 980 262 |
| 2023-05-24 | $11.67 | $11.83 | $11.48 | $11.71 | 1 734 881 |
| 2023-05-23 | $11.81 | $12.12 | $11.68 | $11.75 | 1 786 457 |
| 2023-05-22 | $11.90 | $12.22 | $11.75 | $11.80 | 2 294 785 |
| 2023-05-19 | $11.64 | $12.20 | $11.60 | $11.90 | 2 656 948 |
| 2023-05-18 | $11.08 | $11.52 | $10.93 | $11.51 | 3 022 967 |
| 2023-05-17 | $10.74 | $11.16 | $10.59 | $11.14 | 2 834 029 |
| 2023-05-16 | $10.98 | $10.98 | $10.55 | $10.72 | 2 844 186 |
| 2023-05-15 | $11.27 | $11.45 | $10.91 | $11.20 | 3 151 427 |
| 2023-05-12 | $11.72 | $11.77 | $11.24 | $11.29 | 1 643 566 |
| 2023-05-11 | $11.50 | $11.77 | $11.33 | $11.68 | 2 167 119 |
| 2023-05-10 | $12.29 | $12.49 | $11.49 | $11.58 | 2 594 315 |
| 2023-05-09 | $12.08 | $12.29 | $11.99 | $12.19 | 1 873 217 |
| 2023-05-08 | $12.16 | $12.20 | $11.84 | $12.18 | 1 881 024 |
| 2023-05-05 | $11.94 | $12.19 | $11.83 | $12.15 | 2 659 538 |
| 2023-05-04 | $12.01 | $12.01 | $11.62 | $11.85 | 1 725 807 |
| 2023-05-03 | $11.63 | $12.12 | $11.50 | $12.06 | 2 556 277 |
| 2023-05-02 | $11.83 | $11.88 | $11.52 | $11.55 | 1 576 861 |
| 2023-05-01 | $11.54 | $11.91 | $11.49 | $11.90 | 1 701 508 |
| 2023-04-28 | $11.36 | $11.80 | $11.28 | $11.54 | 1 856 705 |
| 2023-04-27 | $11.56 | $11.66 | $11.38 | $11.40 | 1 065 340 |
| 2023-04-26 | $11.48 | $11.84 | $11.41 | $11.56 | 2 099 804 |
| 2023-04-25 | $11.45 | $11.55 | $11.33 | $11.55 | 1 174 017 |
| 2023-04-24 | $11.38 | $11.58 | $11.26 | $11.49 | 1 148 407 |
| 2023-04-21 | $11.51 | $11.63 | $11.33 | $11.45 | 1 171 018 |
| 2023-04-20 | $11.60 | $11.63 | $11.42 | $11.50 | 1 277 861 |
| 2023-04-19 | $11.83 | $11.88 | $11.66 | $11.68 | 1 083 988 |
| 2023-04-18 | $11.87 | $11.94 | $11.64 | $11.89 | 2 048 840 |
| 2023-04-17 | $11.49 | $11.93 | $11.45 | $11.87 | 2 798 388 |
| 2023-04-14 | $11.56 | $11.77 | $11.28 | $11.40 | 1 081 312 |
| 2023-04-13 | $11.08 | $11.68 | $11.01 | $11.59 | 1 753 933 |
| 2023-04-12 | $11.26 | $11.26 | $11.03 | $11.05 | 898 314 |
| 2023-04-11 | $11.14 | $11.29 | $11.09 | $11.20 | 1 444 974 |
| 2023-04-10 | $11.16 | $11.23 | $10.99 | $11.08 | 1 582 254 |
| 2023-04-06 | $11.11 | $11.23 | $11.00 | $11.22 | 2 310 961 |
| 2023-04-05 | $10.89 | $11.10 | $10.87 | $11.06 | 1 316 311 |
| 2023-04-04 | $11.28 | $11.36 | $10.90 | $10.93 | 1 784 171 |
| 2023-04-03 | $11.13 | $11.34 | $11.05 | $11.26 | 1 429 388 |
| 2023-03-31 | $11.03 | $11.21 | $11.00 | $11.09 | 2 202 503 |
| 2023-03-30 | $11.22 | $11.29 | $10.80 | $10.91 | 2 517 631 |
| 2023-03-29 | $11.26 | $11.30 | $11.13 | $11.23 | 2 115 400 |
| 2023-03-28 | $11.18 | $11.48 | $11.07 | $11.21 | 1 944 221 |
| 2023-03-27 | $11.21 | $11.24 | $10.95 | $11.08 | 3 791 627 |
| 2023-03-24 | $11.12 | $11.19 | $10.84 | $11.11 | 2 084 783 |
| 2023-03-23 | $11.20 | $11.38 | $10.95 | $11.20 | 2 135 823 |
About Amicus Therapeutics
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
